New Drug Benefit Questioned 
This should surprise nobody, and maybe just maybe seniors will note this B.S. when they vote next time. Besides the higher prices guaranteed to drug companies, this Medicare drug program is so complex and convoluted, that many many seniors have no clue what to do. When you want something to work especially with seniors, keep it simple has to be the rule of order. This law is meant to use its purposeful complications to give advantage to insurance companies and drug companies over senior's health!
From washington post article :
http://www.washingtonpost.c om/wp-dyn/content/article/2 005/11/22/AR2005112201662.h tml?referrer=emailarticle
The new Medicare drug benefit fails to deliver drug prices as low as those found at the Department of Veterans Affairs, in Canada and at high-volume U.S. pharmacies, a congressional report said yesterday. It was challenged by a Medicare official as flawed and misleading.
http://www.washingtonpost.c om/wp-dyn/content/article/2 005/11/22/AR2005112201662.h tml?referrer=emailarticle
The new Medicare drug benefit fails to deliver drug prices as low as those found at the Department of Veterans Affairs, in Canada and at high-volume U.S. pharmacies, a congressional report said yesterday. It was challenged by a Medicare official as flawed and misleading.
The report, released yesterday by the Democratic staff of the House Government Reform Committee, found that the average prices of 10 popular drugs being offered to Medicare recipients through 10 well-known insurance plans were 80 percent higher than prices negotiated for the government by Veterans Affairs. The Medicare prices were 60 percent higher than average prices paid by Canadian consumers, the report found. And they were about 3 percent higher than those paid by consumers who got their drugs at Costco stores or online through Drugstore.com.
"The prices offered by the Medicare drug plans are higher than all four benchmarks, in some cases significantly so," the report concluded. "This increases costs to seniors and federal taxpayers and makes it doubtful that the complicated design of Medicare Part D provides any tangible benefit to anyone but drug manufacturers and insurers."
"The prices offered by the Medicare drug plans are higher than all four benchmarks, in some cases significantly so," the report concluded. "This increases costs to seniors and federal taxpayers and makes it doubtful that the complicated design of Medicare Part D provides any tangible benefit to anyone but drug manufacturers and insurers."
KEYWORDS: Medicare drug law, insurance company profits, corporate welfare
Sign up for a Complimentary Member Account... Join the community! It's fast. And it'll allow you to take advantage of all this site's great features!
| < Cunningham to Plead Guilty | Diebold Loses In North Carolina > |
New Drug Benefit Questioned | 0 comments ( topical, editorial, 0 hidden)
